Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Heat Bio is on track to complete design and development of the COVID-19 vaccine in July, and expects its gp96/nCoV-2 expressing cell line to be available for clinical-grade manufacturing with partner, Waisman Biomanufacturing, in early August.
What is pushing this up?
What’s up here?
Looks good here?
Let’s see how it goes
Yeah that’s ever investors dream. Maybe though. Look at NVA*
Close call today
Haha I like how investors shot down the RS vote.
Why is this going down?
It has to continue the run tomorrow
This could run hard
Here we go
This looks ready! GLTA
What’s that?
What is this?
Ugh How does this rebound?
NICE MOVE HERE GOOD LUCK!! LETS GO
BIG ONE HERE
I think this hit bottom will revisit this now. Thank you
Did well today
They canceled the RS correct?
Like the chart! Let’s see what happens...
They canceled the RS so this should run hard imo
Ok what’s going on?
HUGE NEWS!!
This might have hit bottom
I hope so loaded big
Well I hope we can dig ourselves out of this hole
This stock sucks unless you got in early at .40 and your about to dump on NEWS. Prove me wrong?
Approaching $2 very strong
Like what?
LOL thought the same thing
$MNKD
NEWS! Management will also be participating in virtual one-on-one meetings with institutional investors on June 24, 2020.
Looks great today!
Also Brazil sales report
You have to pay to play. Diabetes is way bigger than Coronavirus. Also MNKD supplies the replacement injection device.
Great Close! Blue Skies this week!
News!
Investigator-Initiated Study Shows Switching to Afrezza® Improves Glucose Control with No Additional Hypoglycemia in T2DM
https://newsfilter.io/articles/investigator-initiated-study-shows-switching-to-afrezza-improves-glucose-control-with-no-additional--9d023245cbe7dcee19c820d2154b26d8